Research Nester released a report titled “Precision Cancer Imaging Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global precision cancer imaging market in terms of market segmentation by imaging technique, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The precision cancer imaging market is anticipated to grow at a significant CAGR during the forecast period, i.e., 2019-2027 as a result of increasing demand for improved cancer diagnostic techniques across the globe. Non-invasive diagnostic tests such as precision cancer imaging provides accurate screening without the introduction of any medical device inside the body. This is highly desirable among patients across all the regions.
Detailed description: https://www.researchnester.com/reports/global-precision-cancer-imaging-market/1786
The market is segmented by imaging technique, by end user and by region. On the basis of end user, the market is further bifurcated into hospitals, clinics, diagnostic & imaging centers and others, out of which, the hospitals segment is estimated to grow at the highest rate during the forecast period as a result of rising demand for cancer treatments in hospitals, which can be further attributed to increasing prevalence of cancer around the globe, especially among the geriatric population. Data presented by the American Cancer Society suggested that prevalence of cancer is estimated to increase among people who are 85 or older that are anticipated to contribute to 17% of the total deaths by cancer in 2019.
Regionally, the largest market share is anticipated to be held by the market in North America region on account of growing technological innovations in the healthcare sector. Presence of several diagnostic and imaging techniques in the region is a major factor estimated to drive the market growth during forecast period.
Precision cancer imaging market in Asia-Pacific region is estimated to grow at the highest rate in upcoming years on account of increasing advancements in the healthcare industry and growing occurrence of cancer among the large population in the region.
Rising Demand For Non-Invasive Diagnostic Tests To Drive The Market Growth
Non-invasive nature of precision cancer imaging techniques as well as early detection of cancer made possible by them are important factors supporting the market growth. Moreover, the ease of conducting diagnostic tests and provision of faster and highly accurate results is further leading to the growth of precision cancer imaging market.
High Cost Of Techniques To Restrict The Market Growth
According to W.H.O., about 70% of deaths from cancer occur in low and middle income regions. This data suggests that precision cancer imaging techniques, which are highly expensive, are unaffordable to a large section of the population, a factor which is estimated to restrain the growth of precision cancer imaging market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global precision cancer imaging market which includes company profiling of Becton, Dickinson and Company, Thermo Fisher Scientific, Siemens Medical Solutions, F. Hoffmann-La Roche, Canon Medical Systems, bioMérieux, General Electric Company, Koninklijke Philips N.V., Hitachi Medical Systems and Canon Medical Systems. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global precision cancer imaging market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Request Report Sample@ https://www.researchnester.com/sample-request-1786
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
Contact for more Info:
Ajay Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
The investigative study on the Global Cancer Imaging Systems recently added by Emergen Research sheds light on the current market scope as well as the emerging trends and opportunities of the market.
To provide a deeper understanding of the global market, the report offers a statistical analysis of the global and local production and consumption ratio.
The report also offers a comprehensive analysis of the competitive landscape with company profiles and product portfolios.Get a sample of the report - https://www.emergenresearch.com/request-sample/222 PRIMARY RESEARCH MODEL Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures.
Discussions with the subject matter experts were conducted to obtain quantitative and qualitative information and validate our market research findings.Key Features of the Global Cancer Imaging Systems:· The report offers a deep insight into the market with expert data insights from the industry experts and analysts · Dedicated focus on market growth and restraining factors · Thorough analysis of the market segments includes product types, application spectrum, technology, end-user, and other key segments · SWOT and Porter’s Five Forces analysis along with feasibility analysis and venture return analysis · Current and emerging market trends and growth prospects To read more about the report, visit - https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market MARKET ESTIMATION TECHNIQUE The market estimation is conducted by analyzing the data collected through both secondary and primary research.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market.
Macroeconomic indicators have been taken into consideration to understand the current trends of the market.
Breast Imaging Technologies Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis.The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.What the Breast Imaging Market Looks Like?Predicted to grow at a CAGR of 8.0% during the forecast period, the global Breast Imaging Market is estimated to reach USD 4.6 Billion by the end of 2023.
In 2018, North America to dominate the breast imaging market during the forecast period.Based on technology, the market is segmented into ionizing (mammography, PET-CT, MBI, and PEM) and non-ionizing (breast ultrasound, breast MRI, AWBU, and breast thermography), and other breast imaging technologies (CBCT, electrical impedance tomography, and optical imaging).The ionizing breast imaging technology segment accounted for the largest share of the breast imaging market during the forecast period.
The large share of this market segment is primarily due to the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.Based on type, the mammography market is classified into full-field digital mammography, 3D breast tomosynthesis, and analog mammography.
The 3D breast tomosynthesis segment is expected to witness the highest CAGR during the forecast period.The growing demand for advanced screening technologies and increasing regulatory approvals for 3D breast tomosynthesis systems are the key factors driving the growth of this segment.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=897What Drives the Breast Imaging Market?The growth of the global market for Breast Imaging is primarily influenced by the following factors:Growing Incidence of Breast CancerIncreasing Public-Private Investments, Funds, and GrantsIncreasing Awareness on Early Detection of Breast CancerGrowth in the Aging PopulationGeographical growth scenario of Breast Imaging MarketGeographically, the Breast Imaging market has been studied for North America, Europe, Asia Pacific, and the Rest of the World.
The North American region accounted for the largest share of the breast imaging market in 2018.The rising incidence of breast cancer, easy accessibility and high adoption of advanced diagnostic technologies (owing to the significant per capita annual healthcare expenditure in the US and Canada), and the rapidly increasing geriatric population in the region are some of the major factors driving the growth of the breast imaging market in North America.Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=897Leading market players and strategies adoptedThe prominent players in the Breast Imaging market include Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France).
